Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,778 public trials 699 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL

NCT04134936

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: MorphoSys Research Site Tucson, Arizona, United States

MorphoSys Research Site Anaheim, California, United States

MorphoSys Research Site Duarte, California, United States

MorphoSys Research Site Encinitas, California, United States

View all 70 locations

View Trial Details

Completed

Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT

NCT02692248

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Hospital Universitario Son Espases Palma, Balearic Islands, Spain

Hospital Especialidades Jerez de la Frontera, Cádiz, Spain

Hospital Universitario Donostia Donostia / San Sebastian, Guipúzcoa, Spain

Hospital de Navarra Pamplona, Navarre, Spain

View all 17 locations

View Trial Details

Completed

The Effect of Patient-Family Communication Via Audio Recording

NCT06627725

Conditions: Anxiety, Anxiety Depression (Mild or Not Persistent), Anxiety Disorders, +16 more
Locations: Ordu University Ordu, Turkey (Türkiye)

View Trial Details

Completed

Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"

NCT04213209

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Takeda Selected Site Tokyo, Japan

View Trial Details

Completed

A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects with Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis.

NCT03016013

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +16 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma

NCT02532257

Conditions: Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, Ann Arbor Stage III Follicular Lymphoma, +17 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]

NCT00700258

Conditions: Carcinoma, Carcinoma, Renal Cell, Advanced, Gastrointestinal Stroma Tumors, +11 more
Locations: Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany

Dr. med. Harald Held Neumünster, Schleswig-Holstein, Germany

Dr. med. Hans Wilhelm Duebbers Ahaus, Germany

Dr. Ludwig Fischer von Weikersthal Amberg, Germany

View all 77 locations

View Trial Details

Completed

Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment

NCT01460914

Conditions: Cutaneous T Cell Lymphoma, Graft Versus Host Disease, Graft vs Host Disease, +11 more
Locations: Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Mechanisms of Severe Acute Influenza Consortium (MOSAIC)

NCT00965354

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +15 more
Locations: Alder Hey Children's Foundation NHS Trust Liverpool, United Kingdom

Royal Liverpool University Hospital Liverpool, United Kingdom

Liverpool Women's NHS Foundation Trust Liverpool, United Kingdom

Aintree Hospitals NHS Trust Liverpool, United Kingdom

View Trial Details

Completed

Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL

NCT05557110

Conditions: B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology Suzhou, Jiangsu, China

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions